Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): The DABOs family

Drugs of the Future

Volumn 27, Issue 2, 2002, Pages 159-175

  Artico, Marino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROMETHYLTHIOMETHYLTHIOBENZYLOXOPYRIMIDINE DERIVATIVE; EFAVIRENZ; EMIVIRINE; NEVIRAPINE; PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CHEMICAL MODIFICATION; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; STRUCTURE ANALYSIS; VIRUS INHIBITION;

EID: 84885332080     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2002.027.02.653978     Document Type: Review

References (56)

1. Molecular targets for AIDS therapy
2. Targets and strategies for the antiviral chemotherapy of AIDS
3. Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors
4. Clinically effective HIV-1 protease inhibitors
5. Design and discovery of HIV-1 integrase inhibitors
6. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTts): A chemical survey from lead compounds to selected drugs for clinical trials
7. Development of non-nucleoside reverse transcriptase inhibitors
8. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections
9. Antiviral therapy for human immunodeficiency virus infections
10. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
11. New perspectives for the treatment of HIV infections
12. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
13. Non-nucleoside reverse transcriptase inhibitors: The NNRTI boom
14. Non-nucleoside reverse transcriptase inhibitors
15. A novel lead for specific anti-HIV-1 agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine
16. Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents
17. Preclinical evaluation of MKC-442, a higly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
18. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442
19. Non-nucleoside inhibitors of HIV-1 reverse transcriptase: Molecular modeling and X-ray structure investigations
20. 3,4-Dihydro-6-(3′-methylbenzyl)-2-(2-methylpropyl)thio-4-oxopyrimidine (MC 622)
21. 2OS, two HIV-1 reverse transcriptase inhibitors
22. Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives
23. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
24. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: Synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
25. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylyhio)thymine analogues: Effect of substitutions at the C-6 phenyl ring and at the C-5 position on the anti-HIV-1 activity
26. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio) thymine (HEPT) as potent and selective anti-HIV-1 agents
27. 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): A new class of specific inhibitors of human immunodeficiency virus type 1
28. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors
29. Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type-1
30. Highly potent and selective inhibitors of HIV-1 replication by 6-phenyl thiouracil derivatives
31. Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyl oxopyrimidines
32. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside/inhibitors
33. Dihydro(alkylthio)(naphthylmethyl)oxo pyrimidines: Novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series
34. Anti-HIV active naphthyl analogues of HEPT and DABO
35. Structure-activity relationship studies on new DABOs: Effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity
36. 5-Alkyl-2-alkylthio-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: Novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives
37. Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding
38. High resolution structures of HIV-1 RT from four RT-inhibitor complexes
39. 5-Alkyl-2-[(methylyhiomethyl)thio]-6-(benzyl)-pyrimidin-4(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABOs series
40. Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent non-nucleoside inhibitors of the human immunodeficiency virus reverse transcriptase
41. Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase
42. Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs?
43. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5- alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase
44. Chiral resolution and molecular modeling investigation of rac-2-cyclopentylthio-6-[1-(2,6-difluorophenyl)ethyl]- 3,4-dihydro-5-methylpyrimidin-4(3H)-one (MC-1047), a potent anti-HIV-1 reverse transcriptase agent of the DABO class
45. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones
46. Synthesis of novel HEPT analogues with anti-HIV-1 activity
47. Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase
48. Synthesis and antiviral activity of 4-benzylpyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors
49. Solid phase synthesis of 2,6-disubstituted-4(3H)-pyrimidinones targeting HIV-1 reverse transcriptase
50. An easy synthesis of 5,6-disubstituted acyclouridine derivatives
51. Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
52. Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent